Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
2152628-33-4
Purity
95%
Selpercatinib is a RET receptor tyrosine kinase inhibitor for the treatment of RET-driven non-small cell lung cancer, medullary thyroid cancer, and thyroid cancer in appropriate patient populations.
Properties
Name
Selpercatinib
Smiles
COC=1C=CC(CN2C3CC2CN(C3)C=4C=CC(=CN4)C5=CC(OCC(C)(C)O)=CN6N=CC(C#N)=C56)=CN1
Targets
Please log in to see this information
SDS
LOXO-292 | selpercatinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$130
2 mg
$200
5 mg
$330
10 mg
$572
15 mg
$POA
20 mg
$748
25 mg
$924
30 mg
$1100
35 mg
$1276
40 mg
$1452
45 mg
$1628
50 mg
$1804
75 mg
$3120
100 mg
$POA
Quantity
1
Total amount
$ 330
LOXO-292 | selpercatinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.